Objectives To analyse patient-reported concerns regarding palliative chemotherapy using text mining and to identify how these concerns evolve according to treatment phase and patient characteristics.

Psoas muscle indices, visceral fat distribution, inflammatory markers and 90-day mortality in palliative medicine: retrospective cohort study ...

1 King's College London, Department of Palliative Care, Policy and Rehabilitation, Cicely Saunders Institute, London, UK 2 Palliative Care Team, Guy's and St Thomas' NHS Trust, London, UK ...

Background Moderate-to-severe cancer related fatigue occurs in 45% of patients with cancer and interferes with many aspects of quality of life. Although physical exercise has level 1 evidence for ...

Correspondence to Dr Agnes van der Heide, Erasmus Medical Center, Rotterdam 3015 GD, The Netherlands; a.vanderheide{at}erasmusmc.nl Objectives At the end of life oral fluid intake is often reduced.

Background Trismus, or limitation of mouth opening, is a common and debilitating toxicity affecting 23%–28% of head and neck cancer (HNC) survivors treated with radiotherapy. Beyond its classification ...

Objectives Polypharmacy can increase symptom burden and reduce quality of life in palliative care patients. The Drug Burden Index (DBI) measures patients’ exposure to anticholinergic and sedative ...

Objectives This study aimed to evaluate the quality of life of caregivers of cancer patients admitted to the Medical Oncology Department of Selçuk University Faculty of Medicine and to identify the ...

Background Subcutaneous (SC) administration is the preferred parenteral opioid route in palliative care, while intravenous infusion may allow faster titration. Comparative evidence remains limited.

Objective Physical functioning (PF), emotional functioning (EF), overall quality of life (QOL) and activities of daily living (ADL) such as walking and toilet transfer are the primary outcomes of ...

Background Opioid-induced neurotoxicity (OIN) is a significant complication in palliative care, presenting with symptoms of hypersomnolence, hallucinations, cognitive dysfunction (including delirium), ...

OIN is common. Even within a limited and methodologically heterogeneous literature, prevalence estimates range from 6% to 38% in palliative care populations, with three of the more recent robust ...